• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[噻嗪类利尿剂治疗高钙尿症性结石病患者时钠利尿和尿钙的比较变化]

[Comparative variations in natriuresis and urinary calcium in patients with hypercalciuric lithiasis treated with thiazide diuretics].

作者信息

Jungers P, Lacour B, Daniel J, Chauveau P, Bruneau M, Bailly M

出版信息

Nephrologie. 1984;5(5):202-4.

PMID:6531057
Abstract

Because of the close relation between sodium (Na) and calcium (Ca) tubular reabsorption, restriction of sodium intake has been proposed in hypercalciuric stone formers. We simultaneously measured urinary concentrations of both ions in 30 recurrent stone formers (19 male, 11 female, mean age 40,8 +/- 10,2 years) with fasting hypercalciuria, before and after reduction of calciuria using long-term thiazide (TZ) treatment associated with moderate restriction of calcium intake, without concomitant Na restriction. No recurrence of stones was observed in this group with a 12 to 49 month follow-up. UCa strongly correlated with UNa in both conditions. However, UCa significantly decreased with TZ (128 +/- 32 vs 73 +/- 26 mumol/kg/day, p less than 0.001), whereas neither UNaV (190 +/- 60 vs 202 +/- 57 mmol/day) nor diuresis significantly varied. We conclude that calciuria can be lowered without reduction in Na intake in hypercalciuric stone formers controlled by thiazide treatment.

摘要

由于钠(Na)和钙(Ca)的肾小管重吸收之间存在密切关系,因此有人提出对高钙尿性结石形成者限制钠摄入。我们同时测量了30例复发性结石形成者(19例男性,11例女性,平均年龄40.8±10.2岁)空腹高钙尿时以及使用长期噻嗪类药物(TZ)治疗并适度限制钙摄入但不限制钠摄入来降低钙尿前后两种离子的尿浓度。在12至49个月的随访中,该组未观察到结石复发。在两种情况下,尿钙(UCa)均与尿钠(UNa)密切相关。然而,使用TZ后UCa显著降低(128±32 vs 73±26 μmol/kg/天,p<0.001),而UNaV(190±60 vs 202±57 mmol/天)和尿量均无显著变化。我们得出结论,在噻嗪类药物治疗控制的高钙尿性结石形成者中,不减少钠摄入也可降低钙尿。

相似文献

1
[Comparative variations in natriuresis and urinary calcium in patients with hypercalciuric lithiasis treated with thiazide diuretics].[噻嗪类利尿剂治疗高钙尿症性结石病患者时钠利尿和尿钙的比较变化]
Nephrologie. 1984;5(5):202-4.
2
[Correlation between protein and sodium intake and calciuria in calcium lithiasis].
Nephrologie. 1993;14(6):287-90.
3
Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.通过饮食和药物联合干预预防吸收性高钙尿症中的结石形成和骨质流失。
J Urol. 2003 Feb;169(2):465-9. doi: 10.1097/01.ju.0000047341.55340.19.
4
[Effect of thiazide therapy in the prophylaxis of calcium lithiasis].[噻嗪类疗法在预防钙结石方面的作用]
Arch Esp Urol. 2001 Nov;54(9):1047-54.
5
The effect of thiazide diuretics on carbohydrate-induced calciuria in patients with recurrent renal calculi.噻嗪类利尿剂对复发性肾结石患者碳水化合物诱导的尿钙排泄的影响。
J Lab Clin Med. 1975 Jul;86(1):118-25.
6
[Preventive medical treatment of recurrent urinary calcium calculi].复发性尿路钙结石的预防性医学治疗
Nephrologie. 1986;7(1):9-12.
7
[Idiopathic hypercalciuria in childhood].[儿童特发性高钙尿症]
Orv Hetil. 1998 Dec 6;139(49):2957-62.
8
[Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].[高钙尿症中结石形成风险的预测价值:是否应测量24小时尿钙?]
Nephrologie. 1984;5(5):232-4.
9
[Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].[钙结石的实验与临床研究。II. 噻嗪类药物和别嘌呤醇预防复发性钙结石]
Hinyokika Kiyo. 1986 Sep;32(9):1247-57.
10
Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.噻嗪类药物长期治疗对含钙尿路结石患者尿草酸的降低作用。
Invest Urol. 1980 Sep;18(2):170-3.